Venmax Drugs and Pharmaceuticals Limited (BOM:531015)

BOM:531015 Revenue

Venmax Drugs and Pharmaceuticals had revenue of 24.79M INR in the quarter ending June 30, 2026, with 104.85% growth. This brings the company's revenue in the last twelve months to 92.94M, up 385.68% year-over-year. In the fiscal year ending March 31, 2026, Venmax Drugs and Pharmaceuticals had annual revenue of 80.25M with 894.04% growth.

• Revenue (ttm): 92.94M
• Revenue Growth: +385.68%
• P/S Ratio: 2.00
• Revenue / Employee: 46.47M
• Employees: 2
• Market Cap: 186.25M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	80.25M	72.18M	894.04%
Mar 31, 2025	8.07M	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error